The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N-nitrosodimethylamine (NDMA) – as well as other ranitidine products – increased the risk of cancer.

Tens of thousands of Americans are in line to share $2.2bn (£1.7bn) after GSK agreed a settlement over claims its indigestion ... its heartburn drug Zantac caused cancer. The company said it ...

The case stems from claims emerging in 2019 that Zantac (ranitidine) or generic versions caused cancer and other illnesses ... but this was rejected and the decision is final and cannot be appealed.

claimed that prolonged use of Zantac caused her to develop colon cancer. But a jury on Thursday determined that the medication was not responsible, and the judge rejected her request for 640 ...